Subscribe To
celularity announces $45 million purchase order, first middle east private label agreement for celularity’s halal-certified biomaterial products
Builds on celularity’s December 2022 announcement of Halal Certification of its commercial-stage biom...
May 23, 2023, 12:10 pm
celularity announces phase 1 data showing that mlasc therapy in patients with crohn’s disease may be a therapeutic option to manage inflammatory bowel diseases and prevent fistula formation
Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and Cell Therapy demonstrate that therapy with placental-derive...
May 19, 2023, 8:21 pm
celularity, inc. (celu) is a trending stock: facts to know before betting on it
celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, i...
March 17, 2023, 10:44 am
Here is what to know beyond why celularity, inc. (celu) is a trending stock
Recently, Zacks.com users have been paying close attention to celularity, Inc. (CELU). This makes it wo...
February 20, 2023, 10:32 am
celularity, inc. (celu) is attracting investor attention: here is what you should know
celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, i...
February 8, 2023, 10:32 am
celularity, inc. (celu) is a trending stock: facts to know before betting on it
Zacks.com users have recently been watching celularity, Inc. (CELU) quite a bit. Thus, it is worth know...
January 24, 2023, 10:32 am
Investors heavily search celularity, inc. (celu): here is what you need to know
Zacks.com users have recently been watching celularity, Inc. (CELU) quite a bit. Thus, it is worth know...
January 11, 2023, 10:32 am
After plunging -38.63% in 4 weeks, here's why the trend might reverse for celularity, inc. (celu)
celularity, Inc. (CELU) has become technically an oversold stock now, which implies exhaustion of the h...
January 9, 2023, 11:17 am
celularity’s placental-derived allogeneic cell therapy provides clinically meaningful benefit and durable biological effect in patients with moderate to severe crohn’s disease in phase 1, phase 1b/2a
Legacy studies employing a single treatment course of two infusions seven days apart demonstrated greatest benefit in three early studies Data support...
January 6, 2023, 1:10 pm
Down 29.5% in 4 weeks, here's why you should you buy the dip in celularity, inc. (celu)
celularity, Inc. (CELU) is technically in oversold territory now, so the heavy selling pressure might h...
December 23, 2022, 11:17 am
All you need to know about celularity, inc. (celu) rating upgrade to strong buy
celularity, Inc. (CELU) might move higher on growing optimism about its earnings prospects, which is re...
December 20, 2022, 1:32 pm
Imugene’s oncarlytics combination with celularity’s placental-derived off-the-shelf allogeneic cycart-19 t cells preclinical data presented at sitc annual meeting
SYDNEY, Australia and FLORHAM PARK, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) — Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company and <...
November 10, 2022, 10:00 pm
celularity, inc. (celu) q3 earnings beat estimates
celularity, Inc. (CELU) delivered earnings and revenue surprises of 111.54% and 21.83%, respectively, f...
November 10, 2022, 9:49 pm
Is amerisourcebergen (abc) outperforming other medical stocks this year?
Here is how AmerisourceBergen (ABC) and celularity, Inc. (CELU) have performed compared to their sector...
February 28, 2022, 10:45 am
Is amerisourcebergen (abc) outperforming other medical stocks this year?
Here is how AmerisourceBergen (ABC) and celularity, Inc. (CELU) have performed compared to their sector...
February 28, 2022, 10:45 am
Is amerisourcebergen (abc) outperforming other medical stocks this year?
Here is how AmerisourceBergen (ABC) and celularity, Inc. (CELU) have performed compared to their sector...
February 28, 2022, 10:45 am